CN101396516A - Medicine for treating hypertension - Google Patents

Medicine for treating hypertension Download PDF

Info

Publication number
CN101396516A
CN101396516A CNA2007100171791A CN200710017179A CN101396516A CN 101396516 A CN101396516 A CN 101396516A CN A2007100171791 A CNA2007100171791 A CN A2007100171791A CN 200710017179 A CN200710017179 A CN 200710017179A CN 101396516 A CN101396516 A CN 101396516A
Authority
CN
China
Prior art keywords
parts
medicine
restrains
blood
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007100171791A
Other languages
Chinese (zh)
Inventor
刘若宽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007100171791A priority Critical patent/CN101396516A/en
Publication of CN101396516A publication Critical patent/CN101396516A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese drug, in particular to a drug for treating hypertension. The drug for treating the hypertension is characterized by being made from the following Chinese patent medicines by weight: 7-10 parts of oriental water plantain, 7-10 parts of aweto, 7-10 parts of dwarf lilyturf, 7-10 parts of mistletoe, 7-10 parts of Chinese magnolivine fruit, 7-10 parts of angelica, 7-10 parts of tuckahoe, 7-10 parts of peppermint, 7-10 parts of goldenthread, 7-10 parts of red sage root, 7-10 parts of uncaria, 7-10 parts of Chinese yam, 7-10 parts of dragons blood and 7-10 parts of eucommia bark. The traditional Chinese drug has the advantages of stable blood pressure lowering, good curative effect, quick effect, no toxic and side effect, no relapse after cure and the like.

Description

The hypertensive medicine of a kind of treatment
(1) technical field
The present invention relates to a kind of Chinese medicine, the hypertensive medicine of particularly a kind of treatment.
(2) background technology
Hypertension is a kind of serious harm health, influences a kind of disease of quality of life.Clinical manifestation has headache, mostly occurs at back brain, also is mixed with dizziness, feeling of fullness in the head, and cervical region is pulled sense, tinnitus, dim eyesight, forgetful, insomnia, unhappiness, weak, numb limbs and tense tendons, cardiopalmus etc.Also be to cause hemiplegia of limb, heart failure, cerebral infarction, cerebral hemorrhage, the major reason of renal failure, of common occurrence because of the hypertension lethal case that disables clinically, so the scholar is referred to as meaning " stealthy killer ".
Aspect hypertensive treatment, the common chemical medicine mainly contains following a few class: diuretic, beta-blocker, calcium antagonist, alpha-blocking agent, angiotensin-convertion enzyme inhibitor, angiotensin ii receptor antagonist.More than the conventional antihypertensive drugs of six big classes to the hypertension acute attack, hypertensive crisis and perioperative hypertension etc. have certain therapeutic effect, in the therapeutic process of hypertension, though chemistry medicine effect is rapidly, in the blood pressure lowering process fluctuation of blood pressure big, side effect is also big, can obviously influence water, electrolyte, blood fat, the metabolism of blood glucose etc.; Organs such as the coup injury heart, brain, kidney, simultaneously these medicines are to hyperlipidemia, high blood viscosity, sclerosis of blood vessels, no improvement effects such as the damage of target organ.So Western medicine can only be to have obeyed to fall, fallen and risen, again and again, need take medicine all the life.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, provide a kind of evident in efficacy, can avoid the hypertensive medicine of treatment of taking medicine all the life.
The present invention is achieved through the following technical solutions:
The hypertensive medicine of a kind of treatment, its special character is: the Chinese patent medicine by following parts by weight is made:
Rhizoma Alismatis 7-10 part Cordyceps 7-10 part 7-10 Radix Ophiopogonis part
Herba Taxilli 7-10 part Fructus Schisandrae Chinensis 7-10 part Radix Angelicae Sinensis 7-10 part
Poria 7-10 part Herba Menthae 7-10 part Rhizoma Coptidis 7-10 part
Radix Salviae Miltiorrhizae 7-10 part Ramulus Uncariae Cum Uncis 7-10 part Rhizoma Dioscoreae 7-10 part
Sanguis Draxonis 7-10 part Cortex Eucommiae 7-10 part.
The hypertensive medicine of treatment of the present invention, described medicine are decoction.
Its manufacture method is as follows: the above crude drug that weighing is selected, soak decoction in 1 hour with boiled water, and water boiling back slow fire boiling 35 minutes is filtered promptly.
Instructions of taking: oral, once-a-day, one time 200 milliliters.
The inventor treats 320 routine diabeticss from 1996 so far, and 95% patient is clearly better, and wherein 85.7% patient returns to one's perfect health, and 86.5% complication takes a turn for the better comprehensively.The result is as follows:
Take natural law The uncomfortable change The reparation degree
1-7 (my god) The dizziness that causes because of problems such as blood supplies, headache, insomnia, uncomfortable in chest, breathing hard, have palpitation etc. has slight improvement. Blood pressure descends to some extent
7-10 (my god) The blood supply problem continues to improve, and various malaise symptoms begin to alleviate. Blood pressure continues to improve
11-20 (my god) Blood supply insufficiency is alleviated obviously, and various malaise symptoms alleviate more, indivedual symptoms even disappearance. Blood pressure is fluctuation near normal value but to some extent, and blood fat descends to some extent, and atherosclerosis has slight change.
21-40 (my god) The blood supply problem is alleviated substantially, and how various malaise symptoms disappear, but indivedual symptom also slightly exists.Extremity are numb to be alleviated. Blood pressure is basic normal stable, and blood fat is normal or near normal value.Atherosclerosis has bigger improvement, feels good.
40-60 (my god) Blood supply problem and malaise symptoms complete obiteration, sequela is improved and is begun to appear. The blood pressure normal equilibrium, blood fat is normal, and atherosclerosis is improved obviously, feels very comfortable, has much energy, and head is light.
60-90 (my god) Sequela is constantly improved, limb Atherosclerosis disappears substantially, and QI and blood is smooth
Body obstacle, aphasis etc. recover to some extent, and coronary heart disease is improved significantly. Logical, memory is improved, and face is glossy, walks energetically.
The present invention is in line with start with blood circulation promoting and blood stasis dispelling, blood lipid regulation from hypertensive morbidity root, vessel softening, recover the function of body regulation and control blood pressure, transform and development, can play blood pressure lowering and the double effects of impaired function of human body and the whole medical treatment of complication at complication.Used through over one hundred routine patient's clinical verification since this medicine is succeeded in developing, have following six big outstanding effects: 1, unique vessel softening function; 2, effectively blood fat reducing, blood glue, eliminate the cause of disease that hypertension constantly worsens development; 3, effectively repair the infringement of hypertension to target organ; 4, steadily blood pressure lowering does not rebound; 5, pure Chinese medicinal preparation safety has no side effect; 6, treating both the principal and secondary aspects of a disease is thoroughly cured hypertension.
In a word, medicine of the present invention has suppressing the hyperactive liver and subsiding YANG, supports the kidney YIN nourishing, invigorating qi and benefiting blood, and the spasmolytic voltage stabilizing, it is active to nourish blood, and blood pressure lowering and blood fat reducing recover blood vessel elasticity rapidly, alleviate effects such as cardiac pressure.Effectively generation of control complication and development rapidly in a short time.Steadily blood pressure lowering, good effect, instant effect have no side effect, and do not recur after more, and characteristics such as do not rebound.
(4) specific embodiment
Embodiment 1:
This treats hypertensive medicine, is made by the Chinese patent medicine of following parts by weight: Rhizoma Alismatis 7 restrains, Cordyceps 7 restrains, restrain Radix Ophiopogonis 7, Herba Taxilli 7 restrains, Fructus Schisandrae Chinensis 7 restrains, Radix Angelicae Sinensis 7 restrains, Poria 7 restrains, Herba Menthae 7 restrains, Rhizoma Coptidis 7 restrains, Radix Salviae Miltiorrhizae 7 restrains, Ramulus Uncariae Cum Uncis 7 restrains, Rhizoma Dioscoreae 7 restrains, Sanguis Draxonis 7 restrains, the Cortex Eucommiae 7 restrains.Its manufacture method is as follows: the above crude drug that weighing is selected, soak decoction in 1 hour with boiled water, and water boiling back slow fire boiling 35 minutes is filtered promptly.Instructions of taking: oral, once-a-day, one time 200 milliliters.
Embodiment 2:
This treats hypertensive medicine, is made by the Chinese patent medicine of following parts by weight: Rhizoma Alismatis 10 restrains, Cordyceps 10 restrains, restrain Radix Ophiopogonis 10, Herba Taxilli 10 restrains, Fructus Schisandrae Chinensis 10 restrains, Radix Angelicae Sinensis 10 restrains, Poria 10 restrains, Herba Menthae 10 restrains, Rhizoma Coptidis 10 restrains, Radix Salviae Miltiorrhizae 10 restrains, Ramulus Uncariae Cum Uncis 10 restrains, Rhizoma Dioscoreae 10 restrains, Sanguis Draxonis 10 restrains, the Cortex Eucommiae 10 restrains.Its manufacture method is as follows: the above crude drug that weighing is selected, soak decoction in 1 hour with boiled water, and water boiling back slow fire boiling 35 minutes is filtered promptly.Instructions of taking: oral, once-a-day, one time 200 milliliters.

Claims (2)

1. treat hypertensive medicine for one kind, it is characterized in that: the Chinese patent medicine by following parts by weight is made:
Rhizoma Alismatis 7-10 part Cordyceps 7-10 part 7-10 Radix Ophiopogonis part
Herba Taxilli 7-10 part Fructus Schisandrae Chinensis 7-10 part Radix Angelicae Sinensis 7-10 part
Poria 7-10 part Herba Menthae 7-10 part Rhizoma Coptidis 7-10 part
Radix Salviae Miltiorrhizae 7-10 part Ramulus Uncariae Cum Uncis 7-10 part Rhizoma Dioscoreae 7-10 part
Sanguis Draxonis 7-10 part Cortex Eucommiae 7-10 part.
2. the hypertensive medicine of treatment according to claim 1 is characterized in that: described medicine is a decoction.
CNA2007100171791A 2007-09-29 2007-09-29 Medicine for treating hypertension Pending CN101396516A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007100171791A CN101396516A (en) 2007-09-29 2007-09-29 Medicine for treating hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007100171791A CN101396516A (en) 2007-09-29 2007-09-29 Medicine for treating hypertension

Publications (1)

Publication Number Publication Date
CN101396516A true CN101396516A (en) 2009-04-01

Family

ID=40515516

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007100171791A Pending CN101396516A (en) 2007-09-29 2007-09-29 Medicine for treating hypertension

Country Status (1)

Country Link
CN (1) CN101396516A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112057536A (en) * 2020-08-24 2020-12-11 中国中医科学院广安门医院 Traditional Chinese medicine composition for preventing or/and treating dyslipidemia and application thereof
CN112057535A (en) * 2020-08-24 2020-12-11 中国中医科学院广安门医院 Preparation method of traditional Chinese medicine composition for preventing or/and treating dyslipidemia

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112057536A (en) * 2020-08-24 2020-12-11 中国中医科学院广安门医院 Traditional Chinese medicine composition for preventing or/and treating dyslipidemia and application thereof
CN112057535A (en) * 2020-08-24 2020-12-11 中国中医科学院广安门医院 Preparation method of traditional Chinese medicine composition for preventing or/and treating dyslipidemia
CN112057535B (en) * 2020-08-24 2021-12-31 中国中医科学院广安门医院 Preparation method of traditional Chinese medicine composition for preventing or/and treating dyslipidemia
CN112057536B (en) * 2020-08-24 2021-12-31 中国中医科学院广安门医院 Traditional Chinese medicine composition for preventing or/and treating dyslipidemia and application thereof

Similar Documents

Publication Publication Date Title
CN103212040B (en) Chinese medicinal composition for treatment of seborrheic alopecia
CN102423402B (en) Traditional Chinese drug composition for treating night sweat
CN101537060B (en) Medicine for treating AIDS
CN101579492A (en) Medicine for treating high blood pressure and preparation method thereof
CN102247552A (en) Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases
CN103356952B (en) Chinese medicine composition for treating arrhythmia
CN102327436A (en) Traditional Chinese medicine composition for treating edema during menstruation
CN101396516A (en) Medicine for treating hypertension
CN102784234B (en) Traditional Chinese medicine composition for treating chronic urticaria
CN104352725A (en) Traditional Chinese medicinal composition for treating Parkinson's disease
CN102836275A (en) Medicine for treating hypertension
CN102988860B (en) Traditional Chinese medicine composition for treating vertigo
CN106491893A (en) A kind of Chinese medicine composition for treating hypertension
CN105617198A (en) Method for preparing medicinal liquor for treating wind-cold low back pain
CN104096023A (en) Medicine composition for nursing scoliosis and preparation method thereof
CN104367896B (en) A kind of pharmaceutical composition for treating Qi deficiency blood stasis type apoplexy and preparation method thereof
CN101396515A (en) Medicine for treating hypertension and complication
CN103550727B (en) One treats hypertensive Chinese medicine composition
CN103550530B (en) One treats migrainous Chinese medicine composition
CN102205102B (en) Chinese medical plantar pain-relieving ointment for treating plantar fasciitis
CN105998738A (en) Traditional Chinese medicinal composition for treating night sweat
CN105920440A (en) Chinese medicinal composition for treating edema
CN106606606A (en) Traditional Chinese medicine foot bath preparation used for treating hypertension
CN104127709A (en) Traditional Chinese medicinal composition for curing chronic renal insufficiency
CN104758539A (en) Traditional Chinese medicine composition for treating debilitation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090401